Results 201 to 210 of about 175,224 (302)

Systematic Review of Percutaneous and Transcutaneous Posterior Tibial Neurostimulation for Lower Urinary Tract Symptoms & Lower Urinary Tract Dysfunction in Children. [PDF]

Neurourol Urodyn
Gan ZS, Abdulfattah S, Lege-Matsuura J, Fischer KM, Van Batavia JP.   +4 more
europepmc   +1 more source

Non‐Cyclic Rozanolixizumab Administration in Complex Generalized Myasthenia Gravis

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Rozanolixizumab, an inhibitor of the neonatal Fc receptor (FcRn), is used to treat patients with generalized myasthenia gravis (gMG) refractory to standard therapies. However, the approved six‐week cyclic regimen may be associated with a “wearing‐off” effect and disease fluctuations. We evaluated the non‐cyclic administration
Marc Abi Aoun, Diane Beauvais, Marlène Barnay, Marie‐Hélène Violleau, Stéphane Mathis, Fanny Duval, Guilhem Sole   +6 more
wiley   +1 more source

Bladder Function as a Representation of Systemic Health: An Integrative Framework for Understanding Lower Urinary Tract Symptoms. [PDF]

Int Neurourol J
Kim JW.
europepmc   +1 more source

Pre‐Existing Nocturia Status Predicts Bladder Symptom Exacerbation Following COVID‐19 Vaccination in Women

The Kaohsiung Journal of Medical Sciences, EarlyView.
Hsien‐Che Ou, Hao‐Wei Chen, Yung‐Shun Juan, Yu‐Chen Chen   +3 more
wiley   +1 more source

Phenotyping Overactive Bladder – Part 2: Can Management be Improved by Phenotyping, and Targeting Therapy According to Urgency Type and Other Characteristics? ICI‐RS 2025

Neurourology and Urodynamics, Volume 45, Issue 5, Page 904-913, June 2026.
ABSTRACT Introduction Management of overactive bladder (OAB) has a stepwise approach in adults and children. This does not account for individual patient variations, which may explain suboptimal outcomes in many patients. Distinct OAB profiles, based on patient characteristics, symptoms, urodynamic findings and imaging have been discussed in Part 1 ...
Michel Wyndaele, Michael Samarinas, Apostolos Apostolidis, D. Carolina Ochoa, Giovanni Mosiello, Brigitte Schurch, Pradeep Tyagi, Alan Wein, Paul Abrams, John E. Speich   +9 more
wiley   +1 more source

Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review. [PDF]

Transl Androl Urol
Bakhsh A, Rajih E, Barayan GA, Garah E, Khan I, Alrehaili Z, Alhejaili S, Almuways M, Aloufi T, Alnazawi H, Alharbi A, Farghal D, Badawi A.   +12 more
europepmc   +1 more source

β3‐Adrenoceptor Agonists for Neurogenic Lower Urinary Tract Dysfunction: Evidence and Clinical Rationale for First‐Line Therapy

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Sharon E. Fishberg, Rano Matta
wiley   +1 more source

Financial toxicity in lower urinary tract symptoms amongst men. [PDF]

BMC Urol
Sui W, Suarez P, Yang H, Escobar MCV, Maluf FC, Hall T, Azzawi SA, Gupta L, Chi T.   +8 more
europepmc   +1 more source

Should We Consider Sacral Nerve Stimulation as a Treatment for Neurogenic Lower Urinary Tract Dysfunction? ICI‐RS 2025

Neurourology and Urodynamics, Volume 45, Issue 5, Page 945-950, June 2026.
ABSTRACT Aims To explore the boundary of clinical use of sacral nerve stimulation (SNS) in neurogenic lower urinary tract dysfunction (NLUTD), identifying barriers to approval and early‐impact research questions. Methods This review is derived from a proposal discussion at the International Consultation on Incontinence‐Research Society in Bristol in ...
Marcus J. Drake, Mathijs de Rijk, Stefania Musco, Jalesh Panicker, Michał Późniak, Nikita Bhatt, Brigitte Schurch   +6 more
wiley   +1 more source

Prevalence and Impact of Lower Urinary Tract Symptoms among Women with Rheumatoid Arthritis: A Multicenter Cross-Sectional Study. [PDF]

Med Princ Pract
Alshaikh G, Alsannan B, Aldabeeb D, Almaghlouth II, Almannie RM, Laganà AS, Omair MA.   +6 more
europepmc   +1 more source